DL, A., S, K., HE, A., A, B., M, I., L, K., . . . L, G. (2025). Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS. Multiple sclerosis (Houndmills, Basingstoke, England), 31(7), 821. https://doi.org/10.1177/13524585251325086
Chicago Style (17th ed.) CitationDL, Arnold, et al. "Short- and Long-term Effects of Early Versus Delayed Treatment with Ocrelizumab on Cerebellar Volume Loss in Patients with RMS and PPMS." Multiple Sclerosis (Houndmills, Basingstoke, England) 31, no. 7 (2025): 821. https://doi.org/10.1177/13524585251325086.
MLA (9th ed.) CitationDL, Arnold, et al. "Short- and Long-term Effects of Early Versus Delayed Treatment with Ocrelizumab on Cerebellar Volume Loss in Patients with RMS and PPMS." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 31, no. 7, 2025, p. 821, https://doi.org/10.1177/13524585251325086.